These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 32936523)
41. Transmitted drug resistance mutations and trends of HIV-1 subtypes in treatment-naïve patients: A single-centre experience. Mazzuti L; Melengu T; Falasca F; Calabretto M; Cella E; Ciccozzi M; Mezzaroma I; Iaiani G; Spaziante M; d'Ettorre G; Fimiani C; Vullo V; Antonelli G; Turriziani O J Glob Antimicrob Resist; 2020 Mar; 20():298-303. PubMed ID: 31518723 [TBL] [Abstract][Full Text] [Related]
42. Bridging the gap between HIV epidemiology and antiretroviral resistance evolution: Modelling the spread of resistance in South Africa. Hauser A; Kusejko K; Johnson LF; Wandeler G; Riou J; Goldstein F; Egger M; Kouyos RD PLoS Comput Biol; 2019 Jun; 15(6):e1007083. PubMed ID: 31233494 [TBL] [Abstract][Full Text] [Related]
43. Short communication: HIV type 1 transmitted drug resistance and evidence of transmission clusters among recently infected antiretroviral-naive individuals from Ugandan fishing communities of Lake Victoria. Nazziwa J; Njai HF; Ndembi N; Birungi J; Lyagoba F; Gershim A; Nakiyingi-Miiro J; Nielsen L; Mpendo J; Nanvubya A; Debont J; Grosskurth H; Kamali A; Seeley J; Kaleebu P; AIDS Res Hum Retroviruses; 2013 May; 29(5):788-95. PubMed ID: 23173702 [TBL] [Abstract][Full Text] [Related]
44. Prevalence of Transmitted HIV Drug Resistance Among Recently Infected Persons in San Diego, CA 1996-2013. Panichsillapakit T; Smith DM; Wertheim JO; Richman DD; Little SJ; Mehta SR J Acquir Immune Defic Syndr; 2016 Feb; 71(2):228-36. PubMed ID: 26413846 [TBL] [Abstract][Full Text] [Related]
45. Antiretroviral (ARV) drug resistance in the developing world. Shekelle P; Maglione M; Geotz MB; Wagner G; Wang Z; Hilton L; Carter J; Chen S; Tringle C; Mojica W; Newberry S Evid Rep Technol Assess (Full Rep); 2007 Sep; (156):1-74. PubMed ID: 18088163 [TBL] [Abstract][Full Text] [Related]
46. Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China. Wang Z; Zhang M; Zhang R; Liu L; Shen Y; Wang J; Lu H BMC Infect Dis; 2019 Apr; 19(1):313. PubMed ID: 30961560 [TBL] [Abstract][Full Text] [Related]
47. Temporal Trends in HIV-1 Mutations Used for the Surveillance of Transmitted Drug Resistance. Rhee SY; Tzou PL; Shafer RW Viruses; 2021 May; 13(5):. PubMed ID: 34064774 [TBL] [Abstract][Full Text] [Related]
48. Transmitted drug resistance among antiretroviral-naive patients with established HIV type 1 infection in Santo Domingo, Dominican Republic and review of the Latin American and Caribbean literature. Myers JE; Taylor BS; Rojas Fermín RA; Reyes EV; Vaughan C; José L; Javier C; Franco Estévez R; Donastorg Cabral Y; Batista A; Lie Y; Coakley E; Hammer SM; Brudney K AIDS Res Hum Retroviruses; 2012 Jul; 28(7):667-74. PubMed ID: 21851324 [TBL] [Abstract][Full Text] [Related]
49. Oligonucleotide ligation assay detects HIV drug resistance associated with virologic failure among antiretroviral-naive adults in Kenya. Chung MH; Beck IA; Dross S; Tapia K; Kiarie JN; Richardson BA; Overbaugh J; Sakr SR; John-Stewart GC; Frenkel LM J Acquir Immune Defic Syndr; 2014 Nov; 67(3):246-53. PubMed ID: 25140907 [TBL] [Abstract][Full Text] [Related]
50. Global, regional, and national prevalence of HIV-1 drug resistance in treatment-naive and treatment-experienced children and adolescents: a systematic review and meta-analysis. Ge L; Luo Y; Li X; Hu Y; Sun L; Bu F; Shan D; Liu J EClinicalMedicine; 2024 Nov; 77():102859. PubMed ID: 39430612 [TBL] [Abstract][Full Text] [Related]
51. Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. ; Keiser O; Anastos K; Schechter M; Balestre E; Myer L; Boulle A; Bangsberg D; Touré H; Braitstein P; Sprinz E; Nash D; Hosseinipour M; Dabis F; May M; Brinkhof MW; Egger M Trop Med Int Health; 2008 Jul; 13(7):870-9. PubMed ID: 18373510 [TBL] [Abstract][Full Text] [Related]
52. Increase in transmitted HIV drug resistance among persons undergoing genotypic resistance testing in Ontario, Canada, 2002-09. Burchell AN; Bayoumi AM; Rourke SB; Major C; Gardner S; Sandstrom P; Rachlis A; Taylor D; Mazzulli T; Fisher M; Brooks J; J Antimicrob Chemother; 2012 Nov; 67(11):2755-65. PubMed ID: 22833637 [TBL] [Abstract][Full Text] [Related]
53. Transmitted drug resistance and molecular transmission network among treatment-naive HIV-1 patients in Wenzhou, China, 2020-2023. Zhang T; Dou H; Ye H; Tang H; Wang W; Hu W; Lv B; Zhou M; Dai H; Wang W; Sun B Virol J; 2024 Oct; 21(1):257. PubMed ID: 39420358 [TBL] [Abstract][Full Text] [Related]
54. Applying Next-Generation Sequencing to Track HIV-1 Drug Resistance Mutations Circulating in Portugal. Pimentel V; Pingarilho M; Sebastião CS; Miranda M; Gonçalves F; Cabanas J; Costa I; Diogo I; Fernandes S; Costa O; Corte-Real R; Martins MRO; Seabra SG; Abecasis AB; Gomes P Viruses; 2024 Apr; 16(4):. PubMed ID: 38675962 [TBL] [Abstract][Full Text] [Related]
56. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study. Drescher SM; von Wyl V; Yang WL; Böni J; Yerly S; Shah C; Aubert V; Klimkait T; Taffé P; Furrer H; Battegay M; Ambrosioni J; Cavassini M; Bernasconi E; Vernazza PL; Ledergerber B; Günthard HF; Kouyos RD; Clin Infect Dis; 2014 Jan; 58(2):285-94. PubMed ID: 24145874 [TBL] [Abstract][Full Text] [Related]
57. Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4-8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011-12 and 2012-13. Hunt GM; Ledwaba J; Salimo A; Kalimashe M; Dinh TH; Jackson D; Sherman G; Puren A; Ngandu NK; Lombard C; Morris L; Goga A BMC Infect Dis; 2019 Sep; 19(Suppl 1):787. PubMed ID: 31526373 [TBL] [Abstract][Full Text] [Related]
58. Increase in HIV-1-transmitted drug resistance among ART-naïve youths at the China-Myanmar border during 2009 ~ 2017. Ding Y; Chen M; Wang J; Yang Y; Feng Y; Wang L; Duan S; Lin Q; Xing H; Ma Y; Han M; Ma L BMC Infect Dis; 2021 Jan; 21(1):93. PubMed ID: 33478415 [TBL] [Abstract][Full Text] [Related]
59. Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016. Rossetti B; Di Giambenedetto S; Torti C; Postorino MC; Punzi G; Saladini F; Gennari W; Borghi V; Monno L; Pignataro AR; Polilli E; Colafigli M; Poggi A; Tini S; Zazzi M; De Luca A; HIV Med; 2018 Oct; 19(9):619-628. PubMed ID: 29932313 [TBL] [Abstract][Full Text] [Related]
60. Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States. Ross LL; Shortino D; Shaefer MS AIDS Res Hum Retroviruses; 2018 Aug; 34(8):672-679. PubMed ID: 29732898 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]